Navigation Links
VIA Pharmaceuticals to Host Investor Science Briefing on the Role of Inflammation in Cardiovascular Disease on Tuesday, September 16
Date:9/9/2008

y, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue" or the negative of these terms or other comparable terminology. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond VIA's control and which could materially affect actual results, levels of activity, performance or achievements.

Factors that may cause actual results to differ materially from current expectations include, but are not limited to:
-- our ability to obtain necessary financing;

-- our ability to control our operating expenses;

-- our ability to recruit and enroll patients for the FDG-PET clinical

trial;

-- failure to obtain sufficient data from enrolled patients that can be

used to evaluate VIA-2291, thereby impairing the validity or

statistical significance of our clinical trials;

-- our ability to successfully complete our clinical trials of VIA-2291

on expected timetables and the outcomes of such clinical trials;

-- complexities in designing and implementing cardiovascular clinical

trials using histological examinations, measurement of biomarkers,

medical imaging and atherosclerotic plaque bioassays;

-- the results of our clinical trials, including without limitation, with

respect to the safety and efficacy of VIA-2291;

-- the outcome of any legal proceedings;

-- our ability to obtain necessary FDA approvals;

-- our ability to successfully commercialize VIA-2291;

-- our ability to o
'/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 31, 2014 Today BioSpace , the leading life sciences ... campaign spotlighting the life sciences community in Illinois , ... Kansas , Michigan , Minnesota ... Ohio and Wisconsin . ... of all job postings on BioSpace originating in this region in 2013. ...
(Date:7/31/2014)... famous for a number of breakthroughs, which altered the ... a paper, which laid the foundation of computer science, ... He next played a pivotal role in the Second ... military codes, enabling the Allies to defeat the Nazis ... he turned his attention to artificial intelligence and proposed ...
(Date:7/31/2014)... -- Chemists at Indiana University Bloomington have described ... fashion, a development with potential value for the ... transistors and photovoltaic cells. , Their paper, "Anion-Induced ... Solids and 2D Self-Assembled Crystals," has been published ... of the Royal Society of Chemistry. It is ...
(Date:7/31/2014)... Calif. , July 31, 2014 Rogne ... San Francisco Bay Area , has acquired a ... of Oxford,s commercialisation company. The potent anti-inflammatory activity of ... at the University of Oxford,s Sir William ... company, which has raised over $1.5 million in seed ...
Breaking Biology Technology:Midwest Biotech Leaders Featured On BioSpace Map 2A mathematical theory proposed by Alan Turing in 1952 can explain the formation of fingers 2A mathematical theory proposed by Alan Turing in 1952 can explain the formation of fingers 3Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 2Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 3Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 2Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 3
... NEW YORK, Nov. 30, 2011 Reportlinker.com announces ... in its catalogue: Gene Therapy ... http://www.reportlinker.com/p0203543/Gene-Therapy---technologies-markets-and-companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biological_Therapy Summary ... as the transfer of defined genetic material to ...
... iBio, Inc. (NYSE AMEX: IBIO) today announced that ... requirements for continued listing on the NYSE Amex LLC (the ... for their review, and that the Company is currently awaiting ... announced, the Staff indicated that its review of the Company,s ...
... good chemical sensors, researchers at the University of Illinois ... are better when the graphene is "worse"more imperfections improved ... you would want for transistors, for example," explained Eric ... and a member of the interdisciplinary research team. "Finding ...
Cached Biology Technology:Gene Therapy - Technologies, Markets and Companies 2Gene Therapy - Technologies, Markets and Companies 3Gene Therapy - Technologies, Markets and Companies 4Gene Therapy - Technologies, Markets and Companies 5Gene Therapy - Technologies, Markets and Companies 6Gene Therapy - Technologies, Markets and Companies 7Gene Therapy - Technologies, Markets and Companies 8Gene Therapy - Technologies, Markets and Companies 9Gene Therapy - Technologies, Markets and Companies 10Gene Therapy - Technologies, Markets and Companies 11Gene Therapy - Technologies, Markets and Companies 12Gene Therapy - Technologies, Markets and Companies 13Gene Therapy - Technologies, Markets and Companies 14Gene Therapy - Technologies, Markets and Companies 15Gene Therapy - Technologies, Markets and Companies 16Gene Therapy - Technologies, Markets and Companies 17Gene Therapy - Technologies, Markets and Companies 18Gene Therapy - Technologies, Markets and Companies 19Gene Therapy - Technologies, Markets and Companies 20Gene Therapy - Technologies, Markets and Companies 21iBio, Inc. Submits Plan to Satisfy NYSE Amex Continued Listing Standards 2iBio, Inc. Submits Plan to Satisfy NYSE Amex Continued Listing Standards 3Imperfections may improve graphene sensors 2
(Date:7/31/2014)... biomass burning burning forests to create agricultural ... agriculture and wildfires figures into both climate ... release of a new study by Stanford University ... the degree of that contribution had never been ... paper published July 30 in the Journal ...
(Date:7/31/2014)... Kansas State University researchers have completed a 20-year ... Flint Hills prairie at different times of the ... current late spring time frame has no measurable ... may have multiple benefits. , The study was ... Konza Prairie Biological Station fire chief, and Joseph ...
(Date:7/31/2014)... Do people make a rational choice to be liberal ... Is it a matter of genetics?, Two political scientists ... Rice University say that neither conscious decision-making nor parental ... others lean right. , A growing body of evidence ... the core of political differences, the researchers say in ...
Breaking Biology News(10 mins):Stanford professor finds that wildfires and other burns play bigger role in climate change 2Stanford professor finds that wildfires and other burns play bigger role in climate change 3Stanford professor finds that wildfires and other burns play bigger role in climate change 4Study finds benefits to burning Flint Hills prairie in fall and winter 2Study finds benefits to burning Flint Hills prairie in fall and winter 3Scientists find growing consensus: Political attitudes derive from body and mind 2
... a very large "dead zone" in the Gulf of ... the Chesapeake Bay this year, based on several NOAA-supported ... Michigan, Louisiana State University, and the Louisiana Universities ... Mexico hypoxic "dead" zone will be between 7,286 and ...
... 18, 2013 Joshua Obar, Ph.D., Department of Immunology ... with a 2013 ICAAC Young Investigator Award for his ... memory responses to infection. Obar earned his ... and went on to complete his Ph.D. in Microbiology ...
... 5% and 10% of breast and ovarian cancers are ... tumours are attributable to inherited mutations from the parents ... with these mutations, PARP inhibitors, which are currently in ... a new option for personalised cancer treatment, an alternative ...
Cached Biology News:NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 3NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 4The American Society for Microbiology honors Joshua Obar 2An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2
Anti-Digoxigenin-AP, Fab fragments; from sheep...
2 ml SmartScan Racks...
Request Info...
... The integration of 2D polyacrylamide gel electrophoresis ... regarded as a core technology platform for ... power for complex samples limited only in ... small and large proteins. Quantitative image based ...
Biology Products: